Clinical Nuclear Medicine · 2024 · 23 citations · 5 references
MedicineNuclear MedicineOncologyOncologic Nuclear MedicineRadionuclide TherapyTherapeutic Nuclear MedicineMediastinal TumorsRadioiodine TherapyRadiopharmaceutical TherapyTargeted Radionuclide TherapyTargeted RadiopharmaceuticalsTumor ImagingFibroblast ActivationFibroblast Activation Protein ImagingMolecular Target ImagingRadioligand Therapy ImagingRadiopharmaceutical ImagingRadiopharmaceutical UptakeTargeted Radionuclide ImagingTargeted Radiopharmaceutical Therapy
ABSTRACT: Fibroblast activation protein (FAP) is a new promising molecular target for theragnostic approach. FAP inhibitors (FAPIs) labeled with 177Lu could be potentially a therapeutic radiopharmaceutical. Here, we presented the experience of 4 cycles of 177Lu-FAPI in a 67-year-old man with an unresectable mediastinal sarcoma.
5
<sup>68</sup>Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil, Paul Flechsig, Thomas Lindner et al. · Journal of Nuclear Medicine · 2019 · 1.4K citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Matthew J. Scanlan, B.K. Mohan Raj, Benjamin F. Calvo et al. · Proceedings of the National Academy of Sciences · 1994 · 566 citations · Full text
Medicine, Cell Biology, Oncology +8